- ANI Pharmaceuticals ( NASDAQ: ANIP ) is scheduled to announce Q2 earnings results on Monday, August 8th, before market open.
- The consensus EPS Estimate is $0.22 (-67.2% Y/Y) and the consensus Revenue Estimate is $71.97M (+48.0% Y/Y).
- Over the last 2 years, ANIP has beaten EPS estimates 50% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 1 downward. Revenue estimates have seen 3 upward revisions and 0 downward.
For further details see:
ANI Pharmaceuticals Q2 2022 Earnings Preview